Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$142M |
| 2 |
Procter & Gamble
PG
|
+$74.5M |
| 3 |
PepsiCo
PEP
|
+$60.9M |
| 4 |
Pinduoduo
PDD
|
+$58.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$565M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$337M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 4 |
Walmart Inc
WMT
|
+$314M |
| 5 |
Danaher
DHR
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.98% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Healthcare | 17.12% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Pembina Pipeline
PBA
$27.6B
| $3.42M | 0.02% |
112,713
+11,549
| +11% | +$368K |
|
377
Viatris
VTRS
$18.9B
| $3.42M | 0.02% |
252,805
+5,893
| +2% | +$78.7K |
|
|
CVSA
378
Covista Inc
CVSA
$4.8B
| $3.42M | 0.02% |
115,572
+30,249
| +35% | +$997K |
|
379
Principal Financial Group
PFG
$24.3B
| $3.41M | 0.02% |
47,177
-60,088
| -56% | -$4.19M |
|
380
AtriCure
ATRC
$2.11B
| $3.4M | 0.02% |
48,856
+6,926
| +17% | +$503K |
|
381
e.l.f. Beauty
ELF
$5.81B
| $3.37M | 0.02% |
101,505
+10,408
| +11% | +$323K |
|
|
NARI
382
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.36M | 0.02% |
36,861
-9,400
| -20% | -$806K |
|
383
Adobe
ADBE
$105B
| $3.34M | 0.02% |
5,889
-3,962
| -40% | -$2.48M |
|
384
McCormick & Company Non-Voting
MKC
$14.2B
| $3.28M | 0.02% |
33,957
+26,410
| +350% | +$2.25M |
|
385
Coca-Cola Europacific Partners
CCEP
$47.9B
| $3.25M | 0.02% |
+58,092
| New | +$3.13M |
|
386
Weyerhaeuser
WY
$18.4B
| $3.19M | 0.02% |
77,549
-886
| -1% | -$33.6K |
|
387
HP
HPQ
$27.5B
| $3.17M | 0.02% |
84,279
-71,971
| -46% | -$2.35M |
|
388
MarketAxess Holdings
MKTX
$5.72B
| $3.16M | 0.02% |
7,686
-7,801
| -50% | -$3.08M |
|
389
Allstate
ALL
$67.5B
| $3.14M | 0.02% |
+26,711
| New | +$3.16M |
|
390
Sunrun
RUN
$2.46B
| $3.13M | 0.02% |
+91,330
| New | +$4.27M |
|
391
Gilead Sciences
GILD
$165B
| $3.13M | 0.02% |
43,138
-1,481
| -3% | -$102K |
|
392
AutoZone
AZO
$51.1B
| $3.09M | 0.02% |
1,472
+954
| +184% | +$1.78M |
|
393
Integer Holdings
ITGR
$4.26B
| $3.08M | 0.02% |
36,038
+4,989
| +16% | +$436K |
|
394
Cenovus Energy
CVE
$52.1B
| $3.08M | 0.02% |
250,558
+40,571
| +19% | +$486K |
|
395
Equity Residential
EQR
$25.1B
| $3.07M | 0.02% |
33,930
+18,531
| +120% | +$1.59M |
|
|
PDCO
396
DELISTED
Patterson Companies, Inc.
PDCO
| $3.07M | 0.02% |
104,507
+15,120
| +17% | +$473K |
|
|
TWOU
397
DELISTED
2U Inc
TWOU
| $3.06M | 0.02% |
5,082
+764
| +18% | +$609K |
|
398
Welltower
WELL
$171B
| $3.03M | 0.02% |
35,352
+14,547
| +70% | +$1.21M |
|
|
ONEM
399
DELISTED
1Life Healthcare
ONEM
| $3.03M | 0.02% |
172,539
+4,109
| +2% | +$79.7K |
|
|
CD
400
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $3.01M | 0.02% |
457,387
+94,084
| +26% | +$806K |
|
Similar funds
Ray Dalio's Q4 2021 Portfolio in Review
As of Q4 2021, Ray Dalio held 820 positions worth $17.2B, down 5.8% from $18.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ray Dalio withdrew a net $1.89B in Q4 2021, closing 89 positions and reducing 292 holdings. Its most notable exit was Ecolab, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in RTX Corp worth $16M.
- Ray Dalio's largest Q4 2021 buy was RTX Corp: 186,232 shares worth $16M.
- Ray Dalio added most to Alibaba in Q4 2021, an estimated $142M increase.
- Ray Dalio's biggest Q4 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $565M.
- Ray Dalio fully exited Ecolab in Q4 2021, selling an estimated $14.2M.
- Ray Dalio's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2021.
- Ray Dalio opened 137 new positions and closed 89 in Q4 2021.
- Ray Dalio's portfolio value fell 5.8% quarter-over-quarter to $17.2B.
Based on Bridgewater Associates's 13F filing for Q4 2021, filed 14 Feb 2022.